OpenAI has developed its first AI model dedicated to "longevity"—GPT-4b micro, which is expected to extend human lifespan by 10 years. This groundbreaking achievement may fundamentally reshape humanity’s understanding of aging.
GPT-4b micro uses protein reprogramming technology to increase the efficiency of stem cell generation by 50 times. These AI-optimized proteins far surpass their natural counterparts in converting ordinary cells into stem cells.
Unlike Google DeepMind's AlphaFold, GPT-4b micro acts more like a "protein social expert," precisely predicting interactions between different proteins. These proteins play critical roles in fetal development, serving as a biological "time machine" that can rejuvenate mature cells into youthful, pluripotent stem cells with limitless potential.
This breakthrough AI model opens new possibilities for treating various diseases. Conditions once deemed incurable, such as diabetes and heart disease, may now have a path to potential cures.
Practically speaking, this AI-driven approach could revolutionize organ transplantation. Scientists might be able to create custom organs tailored to individual patients, significantly reducing the risk of rejection and increasing transplant success rates.
GPT-4b micro also marks the first time OpenAI has formally claimed that its AI models can lead to transformative scientific discoveries. This supports OpenAI CEO Sam Altman’s earlier assertion that the company is "confident" it has found a pathway to building AGI (Artificial General Intelligence). Altman believes superintelligent tools can dramatically accelerate scientific discoveries and innovations, far beyond human capabilities.
From AI to nuclear fusion and life extension, Altman is confident in his ability to tackle humanity’s most critical challenges for the future.
Notably, this new model is a collaborative effort between OpenAI and Retro Biosciences, a company in which Altman has invested $180 million. For now, the model is not publicly available, and there is no clear timeline for commercialization.
Resource: OpenAI推首款「抗衰老」AI模型 將幹細胞生成效率提升50倍
